Evaluation of 10-year anesthesia management in patients diagnosed with placenta accreata spectrum and placenta previa: A comparative study

Basit Öğe Kaydı
dc.contributor.authorOygen, Omer
dc.contributor.authorYildirim, Zeynep Baysal
dc.date.accessioned2025-02-22T14:08:42Z
dc.date.available2025-02-22T14:08:42Z
dc.date.issued2024
dc.departmentDicle Üniversitesien_US
dc.description.abstractObjective: In this study, we aimed to evaluate anesthesia management of placenta accreta spectrum disorder and placenta previa who had undergone cesarean section. Materials and methods: The patients were allocated into 2 groups: group 1: general anesthesia, and group 2: spinal anesthesia. Age, gestational age, gravida, parity, previous cesarean section number, anesthesia method applied, preoperative hemoglobin, platelet counts, and postoperative hemoglobin values were recorded. Transfusion applications (erythrocyte suspension, fresh frozen plasma), use of colloid, tranexamic acid, and fibrinogen concentrate were recorded. Results: The mean age of the patients was 32.53 +/- 5.35 years. However, the mean number of gravida was 5.20 +/- 2.33 and the mean parity number was 3.50 +/- 1.92. The preoperative mean hemoglobin value of the pregnant women was 11.28 +/- 1.62 g/dL, and the mean postoperative hemoglobin value was 9.62 +/- 1.43 g/dL. The mean number of previous cesarean sections of the pregnant women was found to be 2.31 +/- 1.03. Patients who underwent spinal anesthesia required less erythrocyte suspension transfusion (80.2% vs 38.9%) (p<0.001). While the rate of hysterectomy in group 2 was 3.7%, hysterectomy had to be performed in 20.6% of the patients in group 1 (p<0.001). There was no statistical difference between the groups in terms of DIC development and acute renal failure (p>0.05). Intraoperative total complications were found to be lower in the spinal anesthesia group (OR: 5.7) (p<0.001). The need for tertiary intensive care was found to be lower in the spinal anesthesia group (p<0.001). No statistically significant difference in terms of mortality. Conclusions: Regardless of which anesthesia technique is used in pregnant women with placenta previa or placenta accreta spectrum diagnosis, it should be kept in mind that serious bleeding may occur during or after cesarean section and that a team should be able to reach the necessary blood and blood products for this.en_US
dc.identifier.doi10.3306/AJHS.2024.39.02.32
dc.identifier.issn1579-5853
dc.identifier.issn2255-0569
dc.identifier.issue2en_US
dc.identifier.urihttps://doi.org/10.3306/AJHS.2024.39.02.32
dc.identifier.urihttps://hdl.handle.net/11468/29581
dc.identifier.volume39en_US
dc.identifier.wosWOS:001186330700004
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherReial Acad Medicina Illes Balearsen_US
dc.relation.ispartofMedicina Balearen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmzKA_WOS_20250222
dc.subjectSpectrum Disorder of Placenta Accretaen_US
dc.subjectPlacenta Previaen_US
dc.subjectAnesthesia managementen_US
dc.subjectTransfusion of blood productsen_US
dc.subjectNeed for intensive careen_US
dc.titleEvaluation of 10-year anesthesia management in patients diagnosed with placenta accreata spectrum and placenta previa: A comparative studyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu